2024-02-25 13:43:35
Vienna (OTS) – Florian Krammer will take over the professorship for infectious medicine (§98) at the Medical University of Vienna on March 1, 2024. The internationally renowned expert in the development of vaccines comes to Vienna from the Icahn School of Medicine at Mount Sinai (USA). His work will alternate between the two institutions.
Florian Krammer is Professor of Vaccinology in the Department of Microbiology at the Icahn School of Medicine at Mount Sinai. His laboratory studies antibody responses to RNA viruses. The main focus is on influenza viruses, but interest also includes antibody responses to coronaviruses, hantaviruses, filoviruses and other emerging RNA viruses. In their studies, the researchers want to elucidate the mechanisms by which these antibodies protect the host from viral infection and disease. The goal is to implement these findings into novel vaccines and therapeutics. A universal influenza virus vaccine developed by Florian Krammer and his team is in clinical development.
Florian Krammer’s focus in Vienna will be on characterizing viral pathogens and developing vaccines and therapies against them. The focus will be on viruses with pandemic potential, also from a local, Austrian perspective. His research will also include human respiratory viruses such as human influenza viruses and SARS-CoV-2.
“I am pleased to welcome Florian Krammer to MedUni Vienna,” explains Rector Markus Müller in a statement, “his expertise in the field of infectious medicine will make a significant contribution to research in this important area. We look forward to benefiting from his expertise and experience and working together to further advance medical research.”
To person
Florian Krammer studied biotechnology at the University of Natural Resources and Life Sciences in Vienna. His dissertation focused on glycoproteins and influenza viruses. Since 2010, Krammer has been researching universal flu vaccines and vaccines against corona, Lassa, Hanta and Ebola viruses at the Institute of Microbiology at the Icahn School of Medicine. Since 2019, he has been the Mount Sinai Professor in Vaccinology and Principal Investigator of the Sinai-Emory Multi-Institutional Collaborative Influenza Vaccine Innovation Center (SEM-CIVIC) as part of an endowed professorship. The goal of CIVIC is to develop improved seasonal and universal influenza virus vaccines that provide long-lasting protection against seasonal, zoonotic and future pandemic influenza viruses. Krammer is also co-director of the Center for Vaccine Research and Pandemic Preparedness (C-VaRPP).
The Krammer lab – which is also part of the NIH-funded Center of Excellence for Influenza Research and Response (CEIRR) – focuses on understanding broad immune responses against the surface glycoproteins of RNA viruses such as influenza with the goal of developing better vaccines and to develop new therapeutics.
Florian Krammer has published more than 400 papers, is a member of the editorial boards of the Journal of Virology, Plos One, Plos Pathogens and Vaccine, is an elected member of the American Academy of Microbiology and the Henry Kunkel Society, and sits on the Board of Directors of the European Scientific Working Group on Influenza and is one of the chairs of the SAVE initiative, which monitors SARS-CoV-2 variants for the US National Institutes of Health.
Questions & Contact:
medical university Vienna
Mag. Johannes Angerer
Head of Communications and Public Relations
+431 40160-1150, +43 664 80016 11501
[email protected]
1708914366
#Florian #Krammer #takes #professorship #infectious #medicine #MedUni #Vienna